NutriBand Inc. Logo

NutriBand Inc.

Develops abuse-deterrent transdermal patches to make potent drug delivery safer.

NTRB | US

Overview

Corporate Details

ISIN(s):
US67092M2089 (+1 more)
LEI:
Country:
United States of America
Address:
121 S. ORANGE AVE., 32801 ORLANDO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nutriband Inc. is a development-stage pharmaceutical company focused on creating transdermal drug delivery systems integrated with abuse-deterrent technology. The company's core platform is its proprietary AVERSA™ technology, designed to prevent the abuse, misuse, and accidental exposure of potent transdermal medications by incorporating aversive agents into the patch. Nutriband's lead product candidate is AVERSA™ Fentanyl, an abuse-deterrent fentanyl patch aimed at improving patient safety and addressing the opioid crisis. The company's mission is to enhance patient outcomes through innovative drug delivery platforms that combine therapeutic efficacy with safety measures against prescription drug abuse.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NutriBand Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NutriBand Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NutriBand Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Personalis, Inc. Logo
Cancer genomics & liquid biopsy for early recurrence detection & guiding precision therapies.
United States of America
PSNL
Perspective Therapeutics, Inc. Logo
Developing targeted alpha radiotherapies using lead-212 to image and treat solid tumors.
United States of America
CATX
PharmAbcine Inc. Logo
Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.
South Korea
208340
Pharma Foods International Co., Ltd. Logo
Researches and sells functional ingredients and direct-to-consumer health & beauty products.
Japan
2929
Pharma Mar S.A. Logo
Develops and commercializes marine-derived oncology treatments for rare cancers.
Spain
PHM
Pharmanutra Logo
Researches and markets nutritional supplements & medical devices for all ages.
Italy
PHN
PHARMARESEARCH BIO Co., Ltd. Logo
A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.
South Korea
217950
PharmaResearch Co., Ltd. Logo
Develops regenerative medicine, devices & cosmetics using marine biotechnology.
South Korea
214450
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany
PSG
Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland
PHR

Talk to a Data Expert

Have a question? We'll get back to you promptly.